pilocarpine has been researched along with sincalide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Habara, Y; Hootman, SR; Kuroiwa, CL | 1 |
Essington, TE; Williams, JA; Yule, DI | 1 |
Gylfe, E; Sjödin, L; Viitanen, E | 1 |
Akiyama, T; Hirohata, Y; Imoto, I; Okabayashi, Y; Otsuki, M | 1 |
1 review(s) available for pilocarpine and sincalide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for pilocarpine and sincalide
Article | Year |
---|---|
Muscarinic receptor desensitization and downregulation induced by full and partial cholinergic agonists in rat pancreatic acini.
Topics: Amylases; Animals; Carbachol; In Vitro Techniques; Kinetics; Male; Pancreas; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Reference Values; Sincalide | 1989 |
Pilocarpine and carbachol exhibit markedly different patterns of Ca2+ signaling in rat pancreatic acinar cells.
Topics: Amylases; Animals; Calcium; Carbachol; Dose-Response Relationship, Drug; Fluorescent Dyes; Fura-2; In Vitro Techniques; Inositol; Inositol Phosphates; Male; Pancreas; Phosphatidylinositols; Pilocarpine; Rats; Rats, Sprague-Dawley; Signal Transduction; Sincalide | 1993 |
Cholecystokinin-JMV-180 and pilocarpine are potent inhibitors of cholecystokinin and carbachol actions on guinea pig pancreatic acinar cells.
Topics: Amylases; Animals; Binding, Competitive; Calcium; Carbachol; Cytoplasm; Dose-Response Relationship, Drug; Guinea Pigs; Islets of Langerhans; Male; Muscarinic Agonists; Pilocarpine; Sincalide | 1997 |
Supramaximal CCK and CCh concentrations abolish VIP potentiation by inhibiting adenylyl cyclase activity.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclase Inhibitors; Amylases; Animals; Bombesin; Carbachol; Cell Membrane; Cholecystokinin; Colforsin; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Kinetics; Male; Pancreas; Pilocarpine; Rats; Rats, Wistar; Sincalide; Tetradecanoylphorbol Acetate; Vasoactive Intestinal Peptide | 1998 |